deSouza, Nandita M. http://orcid.org/0000-0003-4232-476X
van der Lugt, Aad
Deroose, Christophe M.
Alberich-Bayarri, Angel
Bidaut, Luc
Fournier, Laure
Costaridou, Lena
Oprea-Lager, Daniela E.
Kotter, Elmar
Smits, Marion
Mayerhoefer, Marius E.
Boellaard, Ronald
Caroli, Anna
de Geus-Oei, Lioe-Fee
Kunz, Wolfgang G.
Oei, Edwin H.
Lecouvet, Frederic
Franca, Manuela
Loewe, Christian
Lopci, Egesta
Caramella, Caroline
Persson, Anders
Golay, Xavier
Dewey, Marc
O’Connor, James P. B.
deGraaf, Pim
Gatidis, Sergios
Zahlmann, Gudrun
,
,
Article History
Received: 31 May 2022
Accepted: 1 August 2022
First Online: 4 October 2022
Declarations
:
: Not applicable in this mDelphi consensus paper.
: All authors have given consent for publication. Patient consent is not applicable in this mDelphi consensus paper.
: AAB is a member of the <i>Insights into Imaging</i> Editorial Board. He has not taken part in the review or selection process of this article. CL is a Deputy Editor for <i>Insights into Imaging</i>. He has not taken part in the review or selection process of this article. MS is the ESR Publications Committee Chair at the moment of submission. She has not taken part in the review or selection process of this article. MD is the incoming ESR Publications Committee Chair at the moment of submission. He has not taken part in the review or selection process of this article. LF: speaker fees from Sanofi, Novartis, Janssen, General Electric. Congress sponsorship from Guerbet. Industrial grant on radiomics from Invectys, Novartis. Co-investigator in grant with Philips, Ariana Pharma, Evolucare. CC: personal fees from Pfizer, BMS, MSD, Roche and advisory role for Astra Zeneca. CMD: Consulting or advisory roles with Ipsen, Novartis, Terumo, and Advanced Accelerator Applications; participation in speakers’ bureaus with Terumo and Advanced Accelerator Applications; and travel, accommodations, or expenses with General Electric and Terumo. XG: CEO of Gold Standard Phantoms, a company designing calibration devices for quantitative MRI. All remaining authors declare no competing interests.